< Back to all clusters
[HEALTH] · United Kingdom, United States · 3 sources

started · updated

Semaglutide linked to reduced asthma attacks and alcohol misuse

New research suggests that semaglutide, a medication used for type 2 diabetes and weight management, may offer significant respiratory and behavioral health benefits. An observational study presented at the European Respiratory Society Congress in Barcelona, using UK medical records, found that semaglutide is associated with a nearly 40 per cent reduction in asthma attacks and a 20 per cent reduction in COPD flare-ups. The study noted that these benefits were more pronounced in patients receiving higher doses and those with more severe asthma.

Separately, an experimental study published in the American Journal of Psychiatry examined the effects of semaglutide on individuals with moderate to severe alcohol use disorder. While the drug did not reduce overall alcohol cravings or the total number of drinks consumed per day, it significantly decreased the number of heavy drinking days, the amount consumed on those days, and alcohol-related negative consequences. The study also observed a reduction in drinking levels according to World Health Organization risk guidelines.

Entities

Chloe Bloom · European Respiratory Society · Imperial College London · Joseph P. Schacht · semaglutide

Claims

What the coverage asserts, and how many sources carry each claim.

  • [● 2 SOURCES] Semaglutide use is associated with a nearly 40 per cent reduction in asthma attacks. time.news · www.independent.co.uk
  • [○ 1 SOURCE] The connection between semaglutide and reduced respiratory flare-ups was stronger in patients receiving higher doses. www.independent.co.uk
  • [● 2 SOURCES] Semaglutide use is associated with a 20 per cent reduction in COPD flare-ups. time.news · www.independent.co.uk
  • [DISPUTED] Semaglutide did not reduce primary laboratory measures of alcohol craving or total drinks per day in individuals with alcohol use disorder. www.psypost.org
  • [DISPUTED] Semaglutide significantly reduced the number of heavy drinking days and drinks consumed on drinking days in individuals with alcohol use disorder. www.psypost.org